Plans should also ensure Wegovy is added to a transition exclusion list to ensure only Part D eligible medically accepted indications are afforded a transition fill
If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines
Malhotra A et al., SURMOUNT-OSA, NEJM 2024 (NEJMoa2404881, PMID 38912654) : tirzepatide and obstructive sleep apnea, AHI -25,3 to 52 weeks
Each dose increase may bring a temporary return of nausea and other side effects, though usually less severe than the initial experience
In stock $39.99 - $49.99 You save $239.99 - $299.99 You save $71.99 - $89.99 You save $95.99 - $119.99 You save $31.99 - $39.99 You save $31.99 - $39.99 You save $47.99 - $59.99 You save $28.79 - $35.99 You save Support when you need it
If you see anything suspicious, discard it immediately